Beijing Hotgen Biotech (688068) Stock Overview
Engages in the research, development, manufacture, and sale of medical and public safety inspection products of in-vitro diagnostic products in the field of biomedicine. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
688068 Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Beijing Hotgen Biotech Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥75.10 |
| 52 Week High | CN¥262.22 |
| 52 Week Low | CN¥73.45 |
| Beta | 0.45 |
| 1 Month Change | -12.53% |
| 3 Month Change | -43.16% |
| 1 Year Change | -44.37% |
| 3 Year Change | 77.08% |
| 5 Year Change | -34.72% |
| Change since IPO | 56.79% |
Recent News & Updates
Recent updates
Shareholder Returns
| 688068 | CN Life Sciences | CN Market | |
|---|---|---|---|
| 7D | -3.1% | 10.9% | 1.0% |
| 1Y | -44.4% | 42.6% | 32.3% |
Return vs Industry: 688068 underperformed the CN Life Sciences industry which returned 42.6% over the past year.
Return vs Market: 688068 underperformed the CN Market which returned 32.3% over the past year.
Price Volatility
| 688068 volatility | |
|---|---|
| 688068 Average Weekly Movement | 9.8% |
| Life Sciences Industry Average Movement | 6.3% |
| Market Average Movement | 6.6% |
| 10% most volatile stocks in CN Market | 10.6% |
| 10% least volatile stocks in CN Market | 4.0% |
Stable Share Price: 688068's share price has been volatile over the past 3 months compared to the CN market.
Volatility Over Time: 688068's weekly volatility (10%) has been stable over the past year, but is still higher than 75% of CN stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2005 | 946 | Changqing Lin | www.hotgen.com.cn |
Beijing Hotgen Biotech Co., Ltd. engages in the research, development, manufacture, and sale of medical and public safety inspection products of in-vitro diagnostic products in the field of biomedicine. It offers public safety solutions such as drug tasting, customs disease control, bioterrorism and food safety solutions. The company also provides clinical diagnostics and product solutions, including upconversion light, chemiluminescence, sugar capture, microfluidics, and genetic testing for testing of intestinal microorganisms, gastrointestinal foodborne infections, insect-borne diseases, respiratory pathogens, infectious diseases, Ebola virus antigen, biological warfare agents, microorganisms, and mycotoxins.
Beijing Hotgen Biotech Co., Ltd. Fundamentals Summary
| 688068 fundamental statistics | |
|---|---|
| Market cap | CN¥6.60b |
| Earnings (TTM) | -CN¥246.70m |
| Revenue (TTM) | CN¥427.66m |
Is 688068 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 688068 income statement (TTM) | |
|---|---|
| Revenue | CN¥427.66m |
| Cost of Revenue | CN¥180.35m |
| Gross Profit | CN¥247.31m |
| Other Expenses | CN¥494.01m |
| Earnings | -CN¥246.70m |
Last Reported Earnings
Mar 31, 2026
Next Earnings Date
n/a
| Earnings per share (EPS) | -2.81 |
| Gross Margin | 57.83% |
| Net Profit Margin | -57.69% |
| Debt/Equity Ratio | 0% |
How did 688068 perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/06/26 19:44 |
| End of Day Share Price | 2026/06/26 00:00 |
| Earnings | 2026/03/31 |
| Annual Earnings | 2025/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Beijing Hotgen Biotech Co., Ltd. is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Xinming Zhou | Topsperity Securities |